These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8497655)

  • 1. The effects of antiarrhythmic drugs on the signal-averaged electrocardiogram in patients with malignant ventricular arrhythmias.
    Greenspon AJ; Kidwell GA
    Prog Cardiovasc Dis; 1993; 35(6):399-406. PubMed ID: 8497655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of type I antiarrhythmic drugs on the signal-averaged electrocardiogram in patients with malignant ventricular arrhythmias.
    Greenspon AJ; Kidwell GA; DeCaro M; Hessen S
    Pacing Clin Electrophysiol; 1992 Oct; 15(10 Pt 1):1445-53. PubMed ID: 1383955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective prolongation of QRS late potentials by sodium channel blocking antiarrhythmic drugs: relation to slowing of ventricular tachycardia. Electrophysiologic Study Versus Electrocardiographic Monitoring Trial (ESVEM) Investigators.
    Freedman RA; Steinberg JS
    J Am Coll Cardiol; 1991 Apr; 17(5):1017-25. PubMed ID: 1848871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the signal-averaged electrocardiogram in patients presenting with sustained ventricular tachycardia or fibrillation while on an antiarrhythmic drug.
    Nalos PC; Gang ES; Mandel WJ; Myers MR; Oseran DS; Lass Y; Peter T
    Am Heart J; 1988 Jan; 115(1 Pt 1):108-14. PubMed ID: 3336965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of antiarrhythmic efficacy of class I and III agents in patients with ventricular tachycardia by signal-averaged ECG analysis.
    Kulakowski P; Bashir Y; Heald S; Paul V; Anderson MH; Gibson S; Malik M; Camm AJ
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2116-21. PubMed ID: 1279610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of change of signal-averaged electrocardiogram identifies patients with ventricular arrhythmias who are non-responders to amiodarone.
    Brembilla-Perrot B; Claudon O; Houriez P; Beurrier D; Suty-Selton C
    Int J Cardiol; 2002 Apr; 83(1):47-55. PubMed ID: 11959384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and treatment of ventricular arrhythmias: an update.
    McCollam PL; Parker RB
    Clin Pharm; 1991 Mar; 10(3):195-205. PubMed ID: 2040126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pharmacological and non-pharmacological interventions on ventricular late potentials.
    Breithardt G; Borggrefe M; Karbenn U; Schwarzmaier J
    Eur Heart J; 1987 Mar; 8 Suppl A():97-104. PubMed ID: 3556182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of electrical alternans versus signal averaged electrocardiography in predicting the outcome of electrophysiological testing and arrhythmia-free survival.
    Armoundas AA; Rosenbaum DS; Ruskin JN; Garan H; Cohen RJ
    Heart; 1998 Sep; 80(3):251-6. PubMed ID: 9875084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and localization of prolonged epicardial electrograms with 64-lead body surface signal-averaged electrocardiography.
    Freedman RA; Fuller MS; Greenberg GM; Ershler PR; Lux RL; McLaughlin TB; Menlove R; Green LS; Moddrelle D; Krall R
    Circulation; 1991 Aug; 84(2):871-83. PubMed ID: 1860228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavior of late potentials on the body surface during programmed ventricular stimulation.
    Ho DS; Daly M; Richards DA; Uther JB; Ross DL
    J Am Coll Cardiol; 1996 Nov; 28(5):1283-91. PubMed ID: 8890828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inability of the signal-averaged electrocardiogram to determine risk of arrhythmia recurrence in patients with implantable cardioverter defibrillators.
    Epstein AE; Dailey SM; Shepard RB; Kirk KA; Kay GN; Plumb VJ
    Pacing Clin Electrophysiol; 1991 Jul; 14(7):1169-78. PubMed ID: 1715554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of class I drugs on the cycle length of sustained ventricular tachycardia and the signal-averaged electrocardiogram.
    Doi T; Inoue T; Ohnishi Y; Yokoyama M
    Jpn Circ J; 1997 Jun; 61(6):495-502. PubMed ID: 9225195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias.
    Brembilla-Perrot B; Houriez P; Beurrier D; Claudon O; Terrier de la Chaise A; Louis P
    Int J Cardiol; 2001 Aug; 80(1):7-15. PubMed ID: 11532541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic correlates of spontaneous termination of ventricular tachycardia in patients with coronary artery disease.
    Duff HJ; Mitchell LB; Gillis AM; Sheldon RS; Chudleigh L; Cassidy P; Chiamvimonvat N; Wyse DG
    Circulation; 1993 Sep; 88(3):1054-62. PubMed ID: 8353867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current antiarrhythmic drugs: an overview of mechanisms of action and potential clinical utility.
    Singh BN
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):283-301. PubMed ID: 10090235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive prediction of efficacy of type IA antiarrhythmic drugs by the signal-averaged electrocardiogram in patients with coronary artery disease and sustained ventricular tachycardia.
    Hopson JR; Kienzle MG; Aschoff AM; Shirkey DR
    Am J Cardiol; 1993 Aug; 72(3):288-93. PubMed ID: 8342506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy.
    Mancini DM; Wong KL; Simson MB
    Circulation; 1993 Apr; 87(4):1083-92. PubMed ID: 8462136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient with sustained ventricular tachycardia: identification of a responder to amiodarone using signal-averaged electrocardiogram.
    Kobayashi A; Nomura M; Sawa Y; Kawaguchi T; Koshiba K; Yamaguchi K; Kawano T; Wakatsuki T; Tabata T; Nisikado A; Ito S; Nakaya Y
    J Med Invest; 2004 Aug; 51(3-4):247-53. PubMed ID: 15460915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.